Jul 26, 2021 / 11:00PM GMT
Unidentified Company Representative -
As it is now 9:03, we'll commence. Good morning, and welcome to -- and thank you for joining Volpara's Q1 FY 2022 Quarterly Results Investor Webinar. Joining us on the line today is CEO, Dr. Ralph Highnam; CFO, Dr. Craig Hadfield; and Executive Vice President, U.S. Sales and Marketing, Jill Spear. (Operator Instructions) I would like to also remind you that today's presentation is being recorded.
I would now like to hand over to Dr. Ralph Highnam. Please go ahead.
Ralph Highnam - Volpara Health Technologies Limited - MD, Chief Scientist, CEO & Director
Thank you, [Greg]. Well, thank you, everyone, for your time this morning to hear our busy Q1 FY 2022, which ended 30th of June 2021. Volpara is a health technology company who integrate breast care platform, assist in delivery of personalized breast care. This business model is predominantly based on software-as-a-service, or SaaS. And we're on a mission to save families from cancer. There'll be much to cover today, including an update on FY '22 strategy and CRA Health
Q1 2021 Volpara Health Technologies Ltd Cashflow Reports Call Transcript
Jul 27, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers